These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11661919)

  • 21. Hazardous biological activities in outer space.
    McGarrigle P
    Akron Law Rev; 1984; 18(1):103-40. PubMed ID: 11658579
    [No Abstract]   [Full Text] [Related]  

  • 22. The potential for genetic engineering: a proposal for international legal control.
    Gardner BJ
    VA J Int Law; 1976; 16(2):403-29. PubMed ID: 11661343
    [No Abstract]   [Full Text] [Related]  

  • 23. Public debates as failed social dramas: the recombinant DNA controversy.
    Gross AG
    Q J Speech; 1984 Nov; 80(4):397-409. PubMed ID: 16100804
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetic engineering: the people's choice.
    Neustadtl SJ
    Technol Rev; 1976 Dec; 79(2):10-11+. PubMed ID: 11661728
    [No Abstract]   [Full Text] [Related]  

  • 25. The great 'recombinant DNA' controversy and the need for public debate.
    Pearson M
    Sci Forum; 1977 Jun; 10(3):3-4+. PubMed ID: 11650574
    [No Abstract]   [Full Text] [Related]  

  • 26. Recombinant DNA research; proposed actions under guidelines; notice.
    U.S. National Institutes of Health
    Fed Regist; 1988 Apr; 53(74):12752-4. PubMed ID: 11655890
    [No Abstract]   [Full Text] [Related]  

  • 27. Oncogene researchers may run cancer risk.
    Yanchinski S
    New Sci; 1983 Aug; 99(1372):530. PubMed ID: 11655573
    [No Abstract]   [Full Text] [Related]  

  • 28. Ethical and legal issues in patenting new animal life.
    Dresser R
    Jurimetrics; 1988; 28(4):399-435. PubMed ID: 11652544
    [No Abstract]   [Full Text] [Related]  

  • 29. The regulation of recombinant DNA research: the alternative of local control.
    Rosenblatt DP
    Boston Coll Environ Aff Law Rev; 1982; 10(1):37-78. PubMed ID: 11649694
    [No Abstract]   [Full Text] [Related]  

  • 30. From Asilomar to industrial biotechnology: risks, reductionism and regulation.
    Krimsky S
    Sci Cult (Lond); 2005 Dec; 14(4):309-23. PubMed ID: 16619467
    [No Abstract]   [Full Text] [Related]  

  • 31. The ethics of genetic engineering.
    Lucassen E
    J Appl Philos; 1996; 13(1):51-61. PubMed ID: 11660511
    [No Abstract]   [Full Text] [Related]  

  • 32. Recombinant DNA and technology assessment.
    Georgetown Law J; 1977; 11(4):785-878. PubMed ID: 11664859
    [No Abstract]   [Full Text] [Related]  

  • 33. The perils of knitting new life.
    Lappé M
    Am Biol Teach; 1977 Apr; 39(4):200-206, 210. PubMed ID: 11650656
    [No Abstract]   [Full Text] [Related]  

  • 34. Human gene therapy: application, ethics and regulation.
    Baskerville G
    Dickinson Law Rev; 1992; 96(4):733-63. PubMed ID: 11652212
    [No Abstract]   [Full Text] [Related]  

  • 35. Recombinant DNA research; actions under guidelines; notice of actions.
    U.S. National Institutes of Health
    Fed Regist; 1986 May; 51(88):16952-6. PubMed ID: 11655846
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic manipulation: recommendations drafted.
    Norman C
    Nature; 1975 Dec; 258(5536):561-4. PubMed ID: 11643295
    [No Abstract]   [Full Text] [Related]  

  • 37. Tinkering with life.
    Time; 1977 Apr; 109(16):32-34+. PubMed ID: 11661472
    [No Abstract]   [Full Text] [Related]  

  • 38. Recombinant DNA research.
    Skalka AM
    Res Manage; 1978 Jan; 21(1):9-13. PubMed ID: 11662918
    [No Abstract]   [Full Text] [Related]  

  • 39. Recombinant DNA research; actions under guidelines; notice.
    U.S. National Institutes of Health
    Fed Regist; 1984 Sep; 49(179):36052-60. PubMed ID: 11655750
    [No Abstract]   [Full Text] [Related]  

  • 40. The DNA debate.
    Armentrout RW; Randal J
    Med Dimens; 1978; 7(6):14+. PubMed ID: 11663291
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.